Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
January 12th, 2017
This study utilized ultrasonography for diagnosis and follow-up tests to confirm treatment efficacy of Progressive Resistance Exercise (PRE) in breast cancer-related lymphedema (BCRL). Ultrasonography can be applied effectively to ensure diagnosis and treatment of lymphedema.
The overall goal of this procedure is to diagnose breast cancer-related lymphedema and evaluate the therapeutic effect of resistive exercise by using ultrasonography to measure the thickness of subcutaneous tissue. Begin by laying the patient's arm in a supine position with both arms on the bed. Use a pen to mark the midpoint of the wrist crease, the midpoint of the medial and lateral epicondyles at the level of the elbow, in the bicipital groove.
Then connect these points using a ruler. Next, mark the first target area 10 centimeters proximal to the elbow point along the line between the elbow and bicipital groove. In the second target area, 10 centimeters distal to the elbow point along the line between the elbow and the wrist.
Then, switch on the ultrasound system. Enter the 2-D mode of the soft tissue via the keyboard. Set the depth to five centimeters and choose the 14L5 linear array transducer.
Apply sufficient gel to the ultrasound transducer and place it perpendicularly to the upper limb ventral axis. The short axis view to capture the image where the thickness of the gel is at least one centimeter and the soft tissue contours are not distorted. Next, select the calibrator and the software via the keyboard of the ultrasounds system to draw a line between the muscle and the subcutaneous tissue.
Then, measure the thickness of the muscle, defined at the distance between the highest point on the boundary of the bone to the highest point on the boundary portion of the fascia. Finally, measure the thickness of the subcutaneous tissue, defined as the distance from the skin to the fascia. After measuring the upper limb muscle and subcutaneous tissue thickness at baseline, give the patient a 5 kilogram dumbbell and have him or her put on a compression stocking.
Ask the patient to perform the progressive resistant exercises, or PRE, in the following order. Dumbbell fly, tricep extension, one arm bent-over row, bicep curls, dumbbell side raise, and lifting the arms forward. Next, instruct the patient to complete the six exercises twice a day according to the following schedule.
Five times each during the first week, 10 times each during the second week, 15 times each during the third week, 20 times each during the forth week, and 25 times each during the fifth through eighth weeks. Inform the subject to return at four and eight weeks later to measure the thickness of the subcutaneous tissue and muscle of the upper limb again. Finally, after all measurements are collected, analyze the data by comparing the difference between both arms using a paired T test.
Compare the changes in subcutaneous tissue and muscle thickness using a repeated measures ANOVA. According to the tape measurement, arm circumference did not significantly change in the PRE group after four weeks of exercise. However, both proximal and distal arm circumferences showed a significant reduction after eight weeks.
As measured by ultrasonography in the PRE group, the thickness of muscle in the distal part showed a significant increase at four weeks and eight weeks. and the proximal part demonstrated a significant increase in thickness at eight weeks. Lastly, in the PRE group, the thickness of subcutaneous tissue in the affected upper limb significantly decreased after eight weeks.
No significant difference in these parameters was observed in the control group.
View the full transcript and gain access to thousands of scientific videos
Overview
This study utilized ultrasonography for diagnosing and monitoring treatment efficacy in breast cancer-related lymphedema (BCRL). The application of ultrasonography ensures accurate diagnosis and effective treatment of lymphedema.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Rehabilitation
Background
- Breast cancer-related lymphedema is a common complication post-surgery.
- Progressive Resistance Exercise (PRE) is a therapeutic approach.
- Ultrasonography can measure tissue changes effectively.
- Accurate diagnosis is crucial for effective treatment.
Purpose of Study
- To diagnose breast cancer-related lymphedema.
- To evaluate the therapeutic effect of resistive exercise.
- To utilize ultrasonography for measuring subcutaneous tissue thickness.
Methods Used
- Patient's arm positioned supine on a bed.
- Marking anatomical landmarks for measurement.
- Identifying target areas for ultrasonography assessment.
- Measuring thickness of subcutaneous tissue at specified points.
Main Results
- Ultrasonography effectively diagnosed lymphedema.
- Resistive exercise showed positive therapeutic effects.
- Measurement techniques provided reliable data.
- Findings support the use of ultrasonography in clinical settings.
Conclusions
- Ultrasonography is a valuable tool for diagnosing BCRL.
- PRE can be an effective treatment for lymphedema.
- Further research is needed to optimize treatment protocols.
Frequently Asked Questions
Executive Industry Relevance
Ultrasonographic measurement of tissue thickness provides a quantitative, non-invasive method to assess therapeutic interventions in breast cancer-related lymphedema, supporting early-stage target validation in rehabilitation research. This approach enables mechanistic de-risking by linking exercise-induced physiological changes to measurable tissue remodeling, improving predictive confidence in preclinical and translational workflows. The method’s accessibility and reproducibility facilitate cross-functional collaboration in oncology and physiotherapy development pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying changes in subcutaneous and muscle tissue thickness as biomarkers of treatment response.
- Operational Value: Supports biological de-risking through standardized, repeatable measurements that reduce variability in preclinical efficacy assessments.
Screening & Assay Development
- Scientific Value: Provides quantitative dependent variable measurements (tissue thickness) that enable dose-response characterization of exercise or pharmacologic interventions.
- Operational Value: Ensures assay standardization via defined anatomical landmarks and consistent ultrasound settings, enhancing reproducibility across sites.
Translational & Preclinical Research
- Scientific Value: Demonstrates translational continuity by using clinically relevant ultrasonography to monitor tissue remodeling in disease-relevant models.
- Operational Value: Facilitates risk-adjusted advancement decisions by delivering objective, longitudinal data on therapeutic effects.
Pipeline & Workflow Integration
The method integrates into discovery biology by enabling hypothesis testing through measurable tissue changes, into screening via standardized assay readiness, and into translational research by supporting biomarker-aligned outcome measures.
- Discovery Biology: Supports mechanistic de-risking by quantifying tissue-level responses to interventions, clarifying biological activity.
- Screening: Enables reliable compound or intervention evaluation through reproducible, quantitative tissue thickness outputs.
- Analytics: Generates statistical outputs (paired T-test, repeated measures ANOVA) that allow comparison of pre- and post-intervention conditions.
- Translational Research: Connects discovery to preclinical validation by using ultrasonography as a shared measurement modality across settings.
- Enterprise Reuse: Represents a scalable, platform-agnostic capability applicable to multiple tissue remodeling studies in oncology and rehabilitation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by providing direct, quantitative measures of tissue remodeling linked to functional outcomes.
- Operational Value: Enhances standardization and reproducibility through protocolized landmark identification and imaging parameters.
- Strategic Value: Improves go/no-go decisions by delivering objective efficacy data early in development, reducing late-stage failure risk.
- Portfolio Impact: Enables risk-adjusted prioritization of interventions based on measurable biological activity in target tissues.
Implementation Considerations
- Requires expertise in ultrasonographic imaging and anatomical landmark identification for consistent tissue thickness measurement.
- Dependent on access to ultrasound systems with linear array transducers and software for distance calibration.
- Necessitates cross-team standardization of measurement protocols to ensure data comparability across studies and sites.
- Involves adaptation considerations when applying the method to different limb segments or tissue types beyond the upper limb.
- Limited to superficial tissue assessment; cannot measure deep tissue changes without complementary modalities.
